vimarsana.com
Home
Live Updates
MODULAR ATP Study Of The MCRM System Meets Primary Safety And Efficacy Endpoints By Investing.com : vimarsana.com
MODULAR ATP Study Of The MCRM System Meets Primary Safety And Efficacy Endpoints By Investing.com
Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker
Related Keywords
Amsterdam
,
Noord Holland
,
Netherlands
,
Boston
,
Massachusetts
,
United States
,
Kenneth Stein
,
Reinoud Knops
,
Linkedin
,
Boston Scientific
,
Boston Scientific Corporation
,
Securities Exchange
,
Exchange Commission
,
Twitter
,
Heart Rhythm Society
,
Department Of Cardiology
,
Drug Administration
,
Implantable Defibrillator
,
Heart Rhythm
,
New England Journal
,
European Economic
,
Securities Act
,
Securities Exchange Act
,
Annual Report
,
Quarterly Reports
,
vimarsana.com © 2020. All Rights Reserved.